Symbol="NBSE"
AssetType="Common Stock"
Name="NeuBase Therapeutics Inc"
Description="NeuBase Therapeutics, Inc., a preclinical biopharmaceutical company, focuses on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1173281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="3287200"
EBITDA="-23408468"
PERatio="None"
PEGRatio="None"
BookValue="8.55"
DividendPerShare="0"
DividendYield="0"
EPS="-18.6"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.43"
ReturnOnEquityTTM="-0.935"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-18.6"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="140"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.224"
EVToRevenue="-"
EVToEBITDA="0.524"
Beta="0.65"
num_52WeekHigh="29"
num_52WeekLow="1.68"
num_50DayMovingAverage="2.998"
num_200DayMovingAverage="4.131"
SharesOutstanding="1690500"
DividendDate="2019-02-04"
ExDividendDate="None"
symbol="NBSE"
open="1.74"
high="1.82"
low="1.71"
price="1.73"
volume="47022.00"
latest_trading_day="2023-07-18"
previous_close="1.71"
change="0.02"
change_percent="1.1696%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="81"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="356744"
Change_recent_avg="-0.02"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-1.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="1094"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="593"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0006.jpeg"
image_positive_thumbnail_id_1="955"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_positive_thumbnail_id_2="973"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
